Lataa...
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
BACKGROUND: The ‘Prediction Of Survival in Advanced Sorafenib‐treated HCC’ (PROSASH) model addressed the heterogeneous survival of patients with hepatocellular carcinoma (HCC) treated with sorafenib in clinical trials but requires validation in daily clinical practice. This study aimed to validate,...
Tallennettuna:
| Julkaisussa: | Liver Int |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6973249/ https://ncbi.nlm.nih.gov/pubmed/31579990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14270 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|